C85.87 Other specified types of non-Hodgkin lymphoma, spleen

Name of the Condition

• Other specified types of non-Hodgkin lymphoma, spleen
• C85.87

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers affecting the lymphatic system. This code represents NHL types that do not fit into more specific subcategories and are explicitly documented as "other specified" in clinical records, with involvement of the spleen. The lymphatic system, part of the immune system, is involved in fighting infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes (neck, armpits, groin)
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Abdominal pain or swelling
• Persistent cough or chest discomfort
• Itching or skin rashes

Diagnosis

Diagnosis typically involves a physical exam to check for swollen lymph nodes, blood tests to assess blood cell levels, imaging tests like CT or PET scans, and potentially a biopsy to examine lymphatic tissue. The spleen may be evaluated for enlargement or abnormal cell growth through imaging or direct examination.

Treatment Options

Treatment depends on the specific type and progression of the lymphoma and may include chemotherapy, radiation therapy, immunotherapy, or targeted therapy. In some cases, surgery to remove the spleen (splenectomy) may be considered, especially if the spleen is significantly affected.

Prognosis and Follow-Up

Prognosis varies based on the lymphoma type, stage, and patient factors. Regular follow-up appointments are essential to monitor for recurrence or complications. Treatment response and long-term outcomes are assessed through imaging, blood tests, and clinical evaluations.

Complications

• Spread of cancer to other organs
• Weakened immune system increasing infection risk
• Anemia or low blood cell counts
• Organ damage from tumor growth
• Treatment-related side effects (e.g., fatigue, nausea)

Lifestyle & Prevention

• Maintain a balanced diet to support immune function
• Avoid exposure to known carcinogens (e.g., pesticides)
• Practice good hygiene to reduce infection risk
• Stay up-to-date with vaccinations (as recommended by a healthcare provider)
• Manage stress through healthy coping mechanisms

When to Seek Professional Help

Seek medical attention if you experience persistent symptoms such as unexplained weight loss, fever, night sweats, or swollen lymph nodes. Prompt evaluation is important for early diagnosis and treatment planning.

Tips for Medical Coders

This code (C85.87) is used when the clinical documentation specifies non-Hodgkin lymphoma of the spleen that does not fall into a more specific subcategory. Ensure the record clearly documents the spleen as the site and confirms the lymphoma type as "other specified." Verify that no more precise code applies before assigning C85.87.